These findings provide further evidence that T cell infiltration, particularly CD4+ and CD8+ T cells, might be essential to improve treatment outcomes and prognosis in patients with DLBCL (Figure S1). The gene discussed is CD8A; the disease is diffuse large B-cell lymphoma.